Astrana Health, Inc. (ASTH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1.5B 3B 4.5B Q2 '11: 4.1M Q3 '11: 4.2M Q4 '11: 4.6M Q3 '12: 6.3M Q4 '12: 6.8M Q1 '15: 33M Q2 '15: 39.1M Q3 '15: 38.8M Q4 '15: 41.8M Q1 '16: 44M Q2 '16: 46.2M Q3 '16: 49.5M Q4 '16: 54.5M Q1 '17: 57.4M Q2 '17: 126.4M Q3 '17: 208.9M Q4 '17: 285.8M Q1 '18: 394.9M Q2 '18: 436.3M Q3 '18: 505.9M Q4 '18: 519.9M Q1 '19: 491.7M Q2 '19: 499.1M Q3 '19: 488.5M Q4 '19: 560.6M Q1 '20: 630M Q2 '20: 665.1M Q3 '20: 689.1M Q4 '20: 687.2M Q1 '21: 698.1M Q2 '21: 708.6M Q3 '21: 755.6M Q4 '21: 773.9M Q1 '22: 861.1M Q2 '22: 955.2M Q3 '22: 1B Q4 '22: 1.1B Q1 '23: 1.2B Q2 '23: 1.3B Q3 '23: 1.3B Q4 '23: 1.4B Q1 '24: 1.5B Q2 '24: 1.6B Q3 '24: 1.7B Q4 '24: 2B Q1 '25: 2.3B Q2 '25: 2.4B Q3 '25: 2.9B Q4 '25: 3.2B Q1 '26: 3.5B Q2 '26: 3.8B Q3 '11 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Gross Profit TTM

0 700K 1.4M 2.1M Q2 '11: 545.9K Q3 '11: 525.3K Q4 '11: 709.1K Q3 '12: 1.5M Q4 '12: 1.3M Q1 '13: 1.5M Q2 '13: 1.7M Q3 '13: 1.5M Q4 '13: 1.8M Q1 '14: 1.4M Q3 '11 Q3 '12 Q1 '13 Q3 '13 Q1 '14

Operating Income TTM

-50M 0 50M 100M 150M Q3 '12: -258.7K Q4 '12: -1.8M Q1 '16: -7.3M Q2 '16: -7.4M Q3 '16: -9.1M Q4 '16: -9.3M Q1 '17: 10.1M Q2 '17: 15.9M Q3 '17: 39.3M Q4 '18: 88.4M Q1 '19: 62.4M Q2 '19: 70M Q3 '19: 23.5M Q4 '19: 32.4M Q1 '20: 40.1M Q2 '20: 38.3M Q3 '20: 65.6M Q4 '20: 80.5M Q1 '21: 97.9M Q2 '21: 106M Q3 '21: 121.8M Q4 '21: 98.2M Q1 '22: 102.6M Q2 '22: 97M Q3 '22: 93.9M Q4 '22: 104.3M Q1 '23: 100.4M Q2 '23: 112.1M Q3 '23: 101.1M Q4 '23: 84.6M Q1 '24: 92.4M Q2 '24: 95.4M Q3 '24: 84.8M Q4 '24: 89.3M Q1 '25: 79.8M Q2 '25: 70.1M Q3 '25: 60.9M Q4 '25: 78.5M Q1 '26: 86.5M Q2 '26: 100.5M Q3 '16 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-25M 0 25M 50M 75M Q2 '11: -384.4K Q3 '11: -447.1K Q4 '11: -347.9K Q3 '12: -3.7M Q4 '12: -8.5M Q1 '16: -9.3M Q2 '16: -8.2M Q3 '16: -9M Q4 '16: -9.1M Q1 '17: -56.7K Q2 '17: 3.3M Q3 '17: 10.2M Q4 '17: 25.8M Q1 '18: 23.6M Q2 '18: 24.3M Q3 '18: 27.8M Q4 '18: 12M Q1 '19: 10M Q2 '19: 10.8M Q3 '19: 5.4M Q4 '19: 14.1M Q1 '20: 18M Q2 '20: 21.5M Q3 '20: 34.5M Q4 '20: 37.9M Q1 '21: 47M Q2 '21: 52.6M Q3 '21: 70.1M Q4 '21: 72.4M Q1 '22: 73M Q2 '22: 72.3M Q3 '22: 61.2M Q4 '22: 45.2M Q1 '23: 44.5M Q2 '23: 45.8M Q3 '23: 44.6M Q4 '23: 60.7M Q1 '24: 62.4M Q2 '24: 68.4M Q3 '24: 62.5M Q4 '25: 22.5M Q1 '26: 30.2M Q2 '26: 40.5M Q2 '11 Q2 '16 Q4 '17 Q2 '19 Q4 '20 Q2 '22 Q4 '23 Q2 '26

Cost of Revenue TTM

0 1.5B 3B 4.5B Q4 '17: 273.5M Q1 '18: 298.5M Q2 '18: 331.6M Q3 '18: 361.1M Q4 '18: 361.1M Q1 '19: 359.9M Q2 '19: 361.6M Q3 '19: 396.5M Q4 '19: 467.8M Q1 '20: 528.6M Q2 '20: 563.3M Q3 '20: 554M Q4 '20: 539.2M Q1 '21: 535.6M Q2 '21: 535.8M Q3 '21: 561.4M Q4 '21: 596.1M Q1 '22: 676.3M Q2 '22: 770.1M Q3 '22: 863.4M Q4 '22: 944.7M Q1 '23: 1B Q2 '23: 1.1B Q3 '23: 1.1B Q4 '23: 1.2B Q1 '24: 1.2B Q2 '24: 1.3B Q3 '24: 1.5B Q4 '24: 1.8B Q1 '25: 2B Q2 '25: 2.1B Q3 '25: 2.6B Q4 '25: 2.8B Q1 '26: 3.2B Q2 '26: 3.4B Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

-60M 0 60M 120M 180M Q3 '11: -172.7K Q4 '11: -387.5K Q1 '12: -385.5K Q2 '12: -401.4K Q3 '12: -396.1K Q4 '12: 177.7K Q1 '16: -1.8M Q2 '16: -3.6M Q3 '16: -5.9M Q4 '16: -4.2M Q1 '17: 16.9M Q2 '17: 22.8M Q3 '17: 36.5M Q4 '17: 51.8M Q1 '18: 35.5M Q2 '18: 40.5M Q3 '18: 47.4M Q4 '19: 13.7M Q1 '20: 8.3M Q2 '20: 48.3M Q3 '20: 52.4M Q4 '20: 46.2M Q1 '21: 65.4M Q2 '21: 64.9M Q3 '21: 79.9M Q4 '22: 82.1M Q1 '23: 65.8M Q2 '23: 82.6M Q3 '23: 133.9M Q4 '23: 68.2M Q1 '24: 66.5M Q2 '24: 63.9M Q3 '24: 82.4M Q4 '25: 114.6M Q1 '26: 166M Q2 '26: 107.9M Q3 '11 Q4 '12 Q1 '17 Q2 '18 Q3 '20 Q4 '22 Q1 '24 Q2 '26

Free Cash Flow TTM

-60M 0 60M 120M 180M Q4 '12: 162.2K Q1 '16: -2.1M Q2 '16: -4M Q3 '16: -6.3M Q4 '16: -4.6M Q1 '17: 16.3M Q2 '17: 22.3M Q3 '17: 36.1M Q4 '17: 51M Q1 '18: 34.5M Q2 '18: 39.4M Q3 '18: 46.1M Q4 '19: 12.6M Q1 '20: 7.1M Q2 '20: 47.1M Q3 '20: 51.6M Q4 '20: 45M Q1 '21: 64.4M Q2 '21: 56.8M Q3 '21: 62.9M Q4 '22: 59.2M Q1 '23: 54.3M Q2 '23: 61.1M Q3 '23: 111.5M Q4 '23: 39.7M Q1 '24: 43.6M Q2 '24: 49.5M Q3 '24: 69.9M Q4 '25: 104.5M Q1 '26: 155M Q2 '26: 94.4M Q2 '16 Q2 '17 Q2 '18 Q2 '20 Q2 '21 Q2 '23 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '13: 36.4M Q3 '14: 5.4M Q4 '14: 4.9M Q3 '15: 4.9M Q4 '15: 5.4M Q1 '17: 28.4M Q2 '17: 28.4M Q3 '17: 28.4M Q1 '18: 38.1M Q2 '18: 37.9M Q3 '18: 38.4M Q1 '19: 38.1M Q2 '19: 38M Q3 '19: 37.8M Q1 '20: 37.4M Q2 '20: 37.3M Q3 '20: 37.6M Q1 '21: 43.6M Q2 '21: 45.8M Q3 '21: 46.3M Q1 '22: 46M Q2 '22: 46M Q3 '22: 46.2M Q1 '23: 47M Q2 '23: 46.8M Q3 '23: 46.9M Q1 '24: 47.7M Q2 '24: 48M Q3 '24: 48.2M Q1 '25: 48.9M Q2 '25: 49.5M Q3 '25: 49.5M Q1 '26: 49.1M Q2 '26: 49.8M Q3 '15 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.10 -1.40 -0.70 0.00 0.70 1.40 2.10 Q2 '11: -0.02 Q3 '11: -0.02 Q4 '11: -0.02 Q3 '12: -0.12 Q4 '12: -0.26 Q1 '15: -0.76 Q2 '15: -0.93 Q3 '15: -1.30 Q4 '15: -1.26 Q1 '16: -1.79 Q2 '16: -1.50 Q3 '16: -1.62 Q4 '16: -1.60 Q1 '17: -0.59 Q2 '17: -0.30 Q3 '17: 0.13 Q4 '17: 0.90 Q1 '18: 0.81 Q2 '18: 0.81 Q3 '18: 0.85 Q4 '19: 0.37 Q1 '20: 0.48 Q2 '20: 0.58 Q3 '20: 0.93 Q4 '20: 1.01 Q1 '21: 1.20 Q2 '21: 1.29 Q3 '21: 1.58 Q4 '21: 1.59 Q1 '22: 1.59 Q2 '22: 1.57 Q3 '22: 1.33 Q4 '22: 0.98 Q1 '23: 0.96 Q2 '23: 0.98 Q3 '23: 0.95 Q4 '23: 1.29 Q1 '24: 1.32 Q2 '24: 1.44 Q3 '24: 1.30 Q4 '25: 0.47 Q1 '26: 0.62 Q2 '26: 0.83 Q2 '11 Q2 '15 Q4 '16 Q2 '18 Q4 '20 Q2 '22 Q4 '23 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.